Evidence map›Paper›PMID 38177209›Full record

ArticleScientific reports2024

Palladium-based pseudohomogeneous catalyst for highly selective aerobic oxidation of benzylic alcohols to aldehydes.

Homa Targhan, Aram Rezaei, Alireza Aliabadi, Ali Ramazani, Zhefei Zhao, Huajun Zheng

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. pH-responsive magnetic CuFeScientific reports · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Homa TarghanNano Drug Delivery Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Aram RezaeiNano Drug Delivery Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. aram.rezaei@gmail.com.
Alireza AliabadiPharmaceutical Sciences Research Center, School of Pharmacy, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. aliabadi.alireza@gmail.com.
Ali RamazaniDepartment of Chemistry, University of Zanjan, Zanjan, 45371-38791, Iran. aliramazani@gmail.com.
Zhefei ZhaoDepartment of Applied Chemistry, Zhejiang University of Technology, Hangzhou, 310032, China.
Huajun ZhengDepartment of Applied Chemistry, Zhejiang University of Technology, Hangzhou, 310032, China. zhenghj@zjut.edu.cn.
Kermanshah University of Medical Sciences · IRZhejiang University of Technology · CNUniversity of Zanjan · IR

Funding

Kermanshah University of Medical Sciences 4000133
6 · The paper itself

Abstract

This study presents a novel class of pseudohomogeneous catalysts (PHC) based on carbon quantum dots functionalized with terpyridine ligands (CQDs-Tpy) to immobilize and stabilize palladium nanoparticles (Pd NPs). Extensive characterization techniques clearly confirmed the successful stabilization of Pd NPs on CQDs-Tpy. The effectiveness of the catalyst was demonstrated in the selective aerobic oxidation of primary and secondary of benzylic alcohols to aldehydes in the absence of additives and phase transfer catalyst (PTC). Remarkably, the reactions predominantly yielded aldehydes without further oxidation to carboxylic acids. By employing low catalyst loadings (0.13 mol%), high conversions (up to 89%) and excellent selectivity (> 99%) of the aldehyde derivatives were achieved. Moreover, the CQDs-Tpy/Pd NPs catalyst displayed suitable catalytic activity and recyclability, offering potential economic advantages. This promising approach opens up new opportunities in the field of catalysis for designing subnanometric metal-based PHCs.

Identifiers

PMID38177209
PMCPMC10766977
OpenAlexW4390589492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.